Background Evidence on preventing Alzheimer's disease (AD) is challenging to interpret
due to varying study designs with heterogeneous endpoints and credibility. We completed a …

Background Numerous studies have investigated risk factors for Alzheimer disease (AD).
However, at a recent National Institutes of Health State-of-the-Science Conference, an …

Abstract Background The European Prevention of Alzheimer's Dementia (EPAD)
Programme is a pan-European project whose objective is to deliver a platform, adaptive …

This review examines key pharmacological strategies that have been clinically studied for
the primary or secondary prevention of Alzheimer's disease. Much information …

Objectives To assess whether previous research on purported risk or protective factors for
Alzheimer's disease (AD) and cognitive decline is of sufficient strength to warrant specific …

Due to the progressive aging of the population, Alzheimer's disease (AD) is becoming a
healthcare burden of epidemic proportions for which there is currently no cure …

Abstract Alzheimer's disease (AD), the leading cause of dementia, has reached epidemic
proportions, with major social, medical and economical burdens. With no currently available …

Background Definitions and diagnostic criteria for all medical conditions are regularly
subjected to reviews and revisions as knowledge advances. In the field of Alzheimer's …

Alzheimer's disease (AD) is the most common cause of dementia associated with a
progressive neurodegenerative disorder, with a prevalence of 44 million people throughout …

Background The aetiology of Alzheimer's disease (AD) is believed to involve environmental
exposure and genetic susceptibility. The aim of our present systematic review and meta …